Companies Testing Vaccines Pledge Safety, High Standards

By Linda A. Johnson

The top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus signed an unprecedented pledge meant to boost public confidence in any approved vaccines.

The companies said Tuesday that they will stick to the highest ethical and scientific standards in testing and manufacturing and will make the well-being of those getting vaccinated their top priority.

The announcement comes amid worries that the U.S. Food and Drug Administration will be under political pressure to approve a vaccine before tests to prove it is safe and effective are finished.

Meanwhile, public health officials worry that if many Americans don't get the vaccine, it will be harder to reduce the spread of COVID-19.

The pledge was signed by the chief executive officers of American drugmakers Johnson & Johnson, Merck, Moderna, Novavax, and Pfizer, and European companies AstraZeneca, BioNTech, GlaxoSmithKline, and Sanofi. BioNTech has partnered with Pfizer on one of the vaccines now in the final round of human testing. 

More In Business

After Israel’s Attack on Iran, It’s Good Time to Invest Internationally

We may not be headed for a 2008-esque disaster, but increased geopolitical tension paired with the end of the tech boom means volatility could stick around.

Bitcoin Halving Is Today: Here’s What that Means

Bitcoin halving typically raises the value of the cryptocurrency – and it could be an ‘exemplary’ hedge against inflation.

Big Business This Week: Netflix’s Gamble Pays Off, The Halving Is Upon Us and Oh God Rate Cuts

The dreaded Netflix crackdown on profile sharing translated into a major boost in subscribers while the promised rate cuts seem to be a far off fantasy.

Disneyland Is Spending $2 Billion on New Rides, Hotels, and More

Disney’s nearly $2 billion plan means new rides, hotels, and more.

Drones are Altering Farming and Growing Food Forever

When one thinks of agriculture, it brings up thoughts of tractors, yet unmanned drones have found one of their newest homes in agriculture.

Why Aren’t There More IPOs? Blame Fed Chair Powell (And Those Rates)

After the 2021 boom, IPO activity slowed down significantly, in part due to monetary policy – but things are getting moving again with tech-friendly companies like Iboutta and Rubrik making a public debut.

Load More